openPR Logo
Press release

Enteric Disease Testing Market Size Forecasted To Achieve $6.29 Billion By 2029 With Steady Growth

04-04-2025 07:17 AM CET | Health & Medicine

Press release from: The Business Research Company

Enteric Disease Testing

Enteric Disease Testing

The Enteric Disease Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Enteric Disease Testing Market Size and Projected Growth Rate?
The market size for enteric disease testing has seen considerable expansion over the recent years. An escalation from $4.62 billion in 2024 to $4.87 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%, is projected. Factors such as rising concerns over water and food safety, an upsurge in outbreaks and epidemics, the globalization of food supply, an increase in travel-related infections, and regulatory demands contribute to the growth experienced in the historical phase.

In the coming years, the market size for enteric disease testing is predicted to experience robust growth. It is anticipated to reach $6.29 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 6.6%. This growth during the forecast period is primarily due to factors such as the incorporation of telemedicine and remote monitoring, the impacts of climate change, collaboration across sectors, antimicrobial resistance, and the advent of emerging enteric pathogens. Key trends expected during this period encompass molecular diagnostics, incorporation of digital health, application of AI and machine learning, the use of syndromic testing, and point-of-care testing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6118

What Are the Major Segments in the Enteric Disease Testing Market?
The enteric disease testing market covered in this report is segmented -

1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications

Subsegments:
1) By Bacterial Enteric Disease: Salmonella, Escherichia coli (E. coli), Shigella, Campylobacter, Clostridium Difficile (C. diff)
2) By Parasitic Enteric Disease: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella spiralis
3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus
4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

What Are The Driving Enteric Disease Testing Market Evolution?
The surge in diarrhea and hemolytic urea syndrome (HUS) instances is anticipated to fuel the expansion of the enteric disease testing market. The primary source of diarrheal diseases is the ingestion of contaminated food and water. Hemolytic urea syndrome (HUS), a condition that impacts the blood and vascular systems, is most prevalent in children suffering from diarrhea. Diarrhea and HUS are key contributors to mortality rates in children under five. As the numbers of diarrhea and hemolytic surge, the need for testing solutions also escalates, thereby increasing the demand for enteric disease testing solutions. For example, the Centers for Disease Control and Prevention reports that diarrhea is the second highest cause of death in children under 5 years, with 801 thousand deaths worldwide. This represents one in every nine child deaths annually. Consequently, the rising prevalence of enteric diseases is expected to stimulate the growth of the enteric disease testing market.

Which Firms Dominate The Enteric Disease Testing Market Segments?
Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

What Trends Are Expected to Dominate the Enteric Disease Testing Market in the Next 5 Years?
Leading entities in the enteric disease testing market are dedicating resources towards innovating high-end diagnostic options, such as lab tools, to increase diagnostic exactness and elevate patient results. Laboratory tools encompass specialized devices and apparatus utilized in scientific and medical labs to perform examinations, scrutinize specimens, and generate precise data for diagnosis. These apparatuses are crucial in augmenting the accuracy of diagnostic procedures and advancing research in many fields, including enteric disease testing. For instance, Jiangsu Bioperfectus Technologies Co., Ltd., a biotech firm in China, introduced real-time PCR kits tailored for diagnosing gastrointestinal infectious diseases in March 2023. These kits possess exceptional sensitivity and specificity, allowing for the exact detection of minor quantities of nucleic acids in different specimens. Moreover, they enable swift analysis, dramatically reducing processing durations and boosting throughput in diagnostics and research applications.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Which Is The Largest Region In The Enteric Disease Testing Market?
North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Enteric Disease Testing Market?
2. What is the CAGR expected in the Enteric Disease Testing Market?
3. What Are the Key Innovations Transforming the Enteric Disease Testing Industry?
4. Which Region Is Leading the Enteric Disease Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enteric Disease Testing Market Size Forecasted To Achieve $6.29 Billion By 2029 With Steady Growth here

News-ID: 3955040 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and